---
$id: https://graph.org.ai/products/commodity/51273003
$type: Product
source: UNSPSC
code: "51273003"
title: "Dexivacaine"
class: "51273000"
classTitle: "Anaesthetic piperidines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexivacaine

**UNSPSC Code**: 51273003
**Class**: [Anaesthetic piperidines](Anaesthetic piperidines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C15H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QI846AL4NC, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-methyl-, (s)- but generally known as dexivacaine, which bears US NIH Compound Identifier 3032799. European Medicines Agency schedules Dexivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07033MIG. The term DEXIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). DEXIVACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexivacaine under HS 29333999 and SITC 51574. As of Q4 2014, DEXIVACAINE remains the US FDA Preferred Term for this commodity. Dexivacaine bears US NLM identifiers UMLS ID C0604558 and NCI Concept Code C65371. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)C.

